Joseph Marshalek
Torrance, CANPI 1477180016
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,538 of the $1,828 with a category attached, or 84.1%. It is spread thinly across 27 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,047, more than ten times the $20 reported in 2021.
Across 61 payments — averaging $29.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$260
- E.r. Squibb & Sons, L.L.C.$235
- AstraZeneca$165
- Astellas Pharma US Inc$133
- Lilly USA, LLC$90
- EMD Serono, Inc.$89
- plus $856 from 21 others
What the payments were for
- Food & beverage$1,53884%
- Education$29016%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 15 | $66 |
| Oxycodone Hcl | 12 | $61 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.